Faheema Hasan: Chronic Methemoglobinemia Causing Longstanding Tissue Hypoxia and Secondary Erythrocytosis
Faheema Hasan, Associate Professor at United Medicity, shared a post on LinkedIn about a recent article by Naseema Gangat et al, published in American Journal of Hematology, adding:
“Hematology is humbling.
Nothing replaces diligent clinical examination
I recently saw a middle aged male patient referred for evaluation of erythrocytosis.
- Hb 21 g/dL
- TLC 8,900/µL
- Platelets 5 lakh/µL
Peripheral smear otherwise unremarkable.
Marked plethora, no organomegaly.
No smoking, no prior treatment.
The textbook work-up for polycythemia followed:
- EPO greater than 100 mIU/mL (elevated)
- JAK2 — negative
Then further investigations pursued
- SPEP — normal
- ECHO — normal
- Low-dose CT (head/neck, thorax, abdomen) — no pathology
The diagnosis remained elusive.
Because his haematocrit was over 60%, I wanted to re-examine him personally. That second look changed everything.
The patient had deeply pigmented skin. His lips appeared unusually dark, and when I asked further, he said they had looked that way ‘for as long as he could remember’.
As a farmer, his nails were discoloured from years of working with soil — masking another clue.
Cyanosis — that classic grey-blue hue we are trained to recognise — was hidden in plain sight.
I sent an arterial blood gas with methemoglobin estimation.
22% Methemoglobin
Normal: < 1–2%
The final diagnosis:
Chronic methemoglobinemia causing longstanding tissue hypoxia and secondary erythrocytosis.
How and how important and indispensible is clinical examination..
And this paper on Jak negative erythrocytosis is exemplary!!
Work up for cause of possible congenital methemohlobinemia is underway.”
Title: JAK2 Unmutated Erythrocytosis: 2026 Update on Diagnosis and Management
Authors: Naseema Gangat, Natasha Szuber, Ayalew Teffer

Stay updated on an scientific advances with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support